Nipent and renal failure Patient Reports February 13, 2012

Nipent Side Effects Report #4777583-5
Nipent side effect was reported by a Physician from UNITED STATES on Sept 16, 2005. Female patient, 72 years of age, was diagnosed with extranodal marginal zone b-cell lymphoma (malt type) and was treated with Nipent. After drug was administered, patient experienced the following side effects: acidosis, gastroenteritis , renal failure. Nipent dosage: 0.1905 MG/M2 (2 MG/M2, EVERY 21 DAYS), INTRAVENOUS. During the same period patient was treated with RITUXAN, CYTOXAN. Patient was hospitalized. Patient died on 09/15/2005.

Nipent Side Effects Report #5113825-4
Nipent side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 14, 2006. Male patient, 70 years of age, weighting 198.4 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Nipent. After drug was administered, patient experienced the following side effects: renal failure, tumour lysis syndrome. Nipent dosage: 0.1905 MG/M2 (4 MG/M2, 1 IN 21 D), INTRAVENOUS. During the same period patient was treated with RITUXAN, CYCLOPHOSPHAMIDE, ACYCLORVIR, ALLOPURINOL, BACTRIM, LASIC, LASIX. Patient was hospitalized. Patient recovered.

Nipent Side Effects Report #4910446-0
Nipent side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 27, 2006. Male patient, 67 years of age, weighting 215.2 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Nipent. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, cardiomegaly, hepatosplenomegaly, lung consolidation, lung neoplasm, pulmonary fibrosis , renal failure, respiratory failure, sepsis syndrome. Nipent dosage: 0.2143 MG/M2 (4 MG/M2, DAY 1 ON WEEKS 1, 4, 7, 10, 13, AND 16). During the same period patient was treated with RITUXIMAB, CYTOXAN. Patient was hospitalized. Patient died on 01/26/2006.

Nipent Side Effects Report #4928559-6
Nipent side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 10, 2006. Male patient, 67 years of age, weighting 215.2 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Nipent. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, cardiomegaly, hepatosplenomegaly, lung consolidation, lung neoplasm, pulmonary fibrosis , renal failure, sepsis , urinary bladder haemorrhage. Nipent dosage: 0.2143 MG/M2 (4 MG/M2, DAY 1 ON WEEKS 1, 4, 7, 10, 13, AND 16). During the same period patient was treated with RITUXIMAB, CYCLOPHOSPHAMIDE, PREDNISONE. Patient was hospitalized. Patient died on 01/26/2006.


Nipent Side Effects Report #4819645-X
Nipent side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 25, 2005. Male patient, 64 years of age, weighting 199.5 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Nipent. After drug was administered, patient experienced the following side effects: abdominal pain , blood pressure decreased, chills, dehydration, diarrhoea, heart rate increased, pyrexia, renal failure, sepsis . Nipent dosage: 0.0952 MG (2 MG, Q21), INTRAVENOUS. During the same period patient was treated with RITUXIMAB, CYCLOPHOSPHAMIDE, COZAAR, RABEPRAZOLE, CALCIUM CARBONATE, ERGOCALCIFEROL, VERAPAMIL, URSODIOL. Patient was hospitalized. Patient recovered.

Nipent Side Effects Report #4684581-9
Nipent side effect was reported by a Physician from on May 17, 2005. Female patient, 44 years of age, was treated with Nipent. After drug was administered, patient experienced the following side effects: atrial fibrillation , bacterial sepsis, confusional state, cytomegalovirus antigen positive, metabolic acidosis, renal failure. Nipent dosage: 2 MG/M2.#1 ONE CYCLE OF 2 MG/M^2/DAY FOR 3 DAYS, INTRAVENOUS. Patient was hospitalized. Patient died on 02/20/2001.